Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Novo Nordisk A/S (ADR) - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
NVO
New York
2834
https://www.novonordisk.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Novo Nordisk A/S (ADR)
Weight loss drugs and the many use cases in medical treatments
- Apr 19th, 2024 9:32 pm
Got $500? 3 Healthcare Stocks to Buy and Hold Forever
- Apr 19th, 2024 12:15 pm
How The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher
- Apr 18th, 2024 8:02 pm
India's Biocon developing its own version of Wegovy, clinical trial likely next year
- Apr 18th, 2024 4:23 pm
Is Eli Lilly Stock A Buy After Weight-Loss Drug Succeeds In Sleep Apnea Patients?
- Apr 18th, 2024 4:01 pm
Eli Lilly's (LLY) Tirzepatide Meets Goals in Sleep Apnea Studies
- Apr 18th, 2024 12:51 pm
Metsera, a well-funded obesity drug startup, sees chance to challenge Lilly, Novo
- Apr 18th, 2024 7:00 am
Novo Nordisk (NVO) Stock Falls Amid Market Uptick: What Investors Need to Know
- Apr 16th, 2024 9:45 pm
The Zacks Analyst Blog Highlights Microsoft, Novo Nordisk, United Parcel Service, Booking and Elevance Health
- Apr 16th, 2024 9:07 am
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
- Apr 15th, 2024 5:39 pm
Top Analyst Reports for Microsoft, Novo Nordisk & United Parcel
- Apr 15th, 2024 3:22 pm
Novo Nordisk and Ginkgo Bioworks Are Teaming Up. Here's Why That's Bullish for Both Stocks.
- Apr 15th, 2024 2:00 pm
Beat the Market the Zacks Way: MediaAlpha, NVIDIA, Walmart in Focus
- Apr 15th, 2024 12:43 pm
Novo Nordisk A/S - share repurchase programme
- Apr 15th, 2024 12:43 pm
Nvidia Leads 5 Stocks Near Buy Points As S&P 500 Tests Key Level
- Apr 13th, 2024 3:16 pm
Eli Lilly, Novo Euphoria Risks Disappointing Investors, Goldman Says
- Apr 12th, 2024 8:06 pm
European regulator concludes no suicide link to obesity drugs
- Apr 12th, 2024 11:45 am
7 A-Rated Aggressive Biotech Stocks to Bet On in 2024
- Apr 12th, 2024 10:40 am
Shed the Fat, Gain the Profits: 3 Weight-Loss Stocks to Own Until 2027
- Apr 12th, 2024 10:25 am
All-Time High Flyers: 7 Stocks to Buy as the Market Peaks
- Apr 11th, 2024 4:17 pm
Scroll